Kai Li

机构：Nanchang University, Sun Yat-sen University, Harbin Institute of Technology, Second Affiliated Hospital of Nanchang University, Sun Yat-sen University Cancer Center, University of Hong Kong · ORCID：0009-0000-2832-4822

发表论文 29 篇 · 总被引 1924 次 · h-index 13

代表论文

Myeloid-derived suppressor cells as immunosuppressive regulators and therapeutic targets in cancer (2021 · Signal Transduction and Targeted Therapy · 被引 963)
All‐Natural Immunomodulatory Bioadhesive Hydrogel Promotes Angiogenesis and Diabetic Wound Healing by Regulating Macrophage Heterogeneity (2023 · Advanced Science · 被引 299)
A PD-L1-targeting chimeric switch receptor enhances efficacy of CAR-T cell for pleural and peritoneal metastasis (2022 · Signal Transduction and Targeted Therapy · 被引 51)
Immunosuppressive Tumor Microenvironment and Immunotherapy of Epstein–Barr Virus-Associated Malignancies (2022 · Viruses · 被引 44)
Myeloid-Derived Suppressor Cells: Implications in the Resistance of Malignant Tumors to T Cell-Based Immunotherapy (2021 · Frontiers in Cell and Developmental Biology · 被引 37)
Rheb1 deletion in myeloid cells aggravates OVA-induced allergic inflammation in mice (2017 · Scientific Reports · 被引 29)